You have 9 free searches left this month | to do more

tucatinib

Tucatinib is a drug used to treat Breast Cancer, Healthy, Drug-drug Interaction, and other conditions. Tucatinib is being actively studied in 19 studies and prior, has been studied in 7.

Top SponsorsTop SitesTop Investigators
Seagen Inc.Duke University Medical CenterErica Stringer-Reasor
Alliance for Clinical Trials in OncologyLombardi Cancer Center / Georgetown University Medical CenterJose Pablo Leone
AstraZenecaNorthwest Cancer Specialists, P.C.Reva Basho
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Tucatinib
  • +3 more
  • Parkville, Victoria, Australia
    Peter MacCallum Cancer Centre
2021-03-09
Mar 9, 2021
S
Recruiting
  • HER2 Positive Breast Neoplasms
  • Tucatinib
  • +4 more
  • Baltimore, Maryland
    Mercy Medical Center -Weinberg Center
2021-11-23
Nov 23, 2021
R
Recruiting
  • Breast Cancer
  • +3 more
  • Tucatinib
  • +2 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
2021-07-27
Jul 27, 2021
D
Withdrawn
  • Breast Cancer
  • Tucatinib
  • +3 more
  • (no location specified)
2020-10-21
Oct 21, 2020
P
Not yet recruiting
  • Breast Cancer Stage IV
  • Tucatinib
  • Clackamas, Oregon
  • +3 more
2021-05-17
May 17, 2021
S
Approved for marketing
  • HER2-positive Breast Cancer
  • Tucatinib
  • +2 more
  • (no location specified)
2020-05-05
May 5, 2020
S
No longer available
    • Tucatinib
    • (no location specified)
    2020-02-21
    Feb 21, 2020
    S
    Completed
    • HER2 Positive Metastatic Breast Cancers
    • Tucatinib
    • +2 more
    • Aurora, Colorado
    • +4 more
    2020-06-02
    Jun 2, 2020
    S
    Completed
    • Drug-drug Interaction
    • tucatinib
    • +7 more
    • Daytona Beach, Florida
    • +1 more
    2019-12-16
    Dec 16, 2019
    S
    Recruiting
    • Colorectal Carcinoma
    • +5 more
    • tucatinib
    • +6 more
    • Phoenix, Arizona
    • +11 more
    2021-11-19
    Nov 19, 2021
    U
    Not yet recruiting
    • Metastatic Breast Cancer With a Isolated Brain Progression
    • Tucatinib
    • +3 more
    • Angers, France
    • +30 more
    2021-11-08
    Nov 8, 2021
    U
    Active, not recruiting
    • Metastatic Breast Cancer
    • Leptomeningeal Disease
    • Tucatinib
    • +2 more
    • Birmingham, Alabama
    • +8 more
    2021-10-12
    Oct 12, 2021
    S
    Completed
    • Healthy
    • Tucatinib
    • Glendale, California
      PAREXEL International, Early Phase Clinical Unit - Los Angeles
    2019-09-03
    Sep 3, 2019
    S
    Not yet recruiting
    • HER2-positive Breast Cancer
    • +3 more
    • (no location specified)
    2021-10-12
    Oct 12, 2021
    S
    Recruiting
    • Breast Cancer
    • tucatinib
    • trastuzumab deruxtecan
    • Birmingham, Alabama
    • +31 more
    2021-11-05
    Nov 5, 2021
    S
    Completed
    • Drug-drug Interaction
    • Tucatinib
    • +2 more
    • Salt Lake City, Utah
      Pharmaceutical Research Associates
    2019-03-25
    Mar 25, 2019
    S
    Completed
    • Healthy
    • tucatinib
    • +2 more
    • Dallas, Texas
      Covance Clinical Research Unit - Dallas
    2019-04-11
    Apr 11, 2019
    Z
    Recruiting
    • HER2-expressing Cancers
    • ZW25 (Zanidatamab)
    • +4 more
    • Birmingham, Alabama
    • +16 more
    2021-07-28
    Jul 28, 2021
    S
    Completed
    • Hepatic Impairment
    • Tucatinib
    • Tustin, California
    • +3 more
    2019-05-16
    May 16, 2019
    S
    Recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • tucatinib
    • +5 more
    • Phoenix, Arizona
    • +34 more
    2021-10-01
    Oct 1, 2021
    S
    Recruiting
    • Uterine Neoplasms
    • +5 more
    • tucatinib
    • +2 more
    • Phoenix, Arizona
    • +44 more
    2021-11-05
    Nov 5, 2021
    S
    Active, not recruiting
    • Metastatic Colorectal Adenocarcinoma
    • Birmingham, Alabama
    • +55 more
    2021-11-19
    Nov 19, 2021
    C
    Completed
    • Healthy
    • tucatinib
    • Madison, Wisconsin
      Covance Clinical Research Unit
    2018-11-28
    Nov 28, 2018
    S
    Active, not recruiting
    • HER2 Positive Breast Cancer
    • tucatinib
    • +3 more
    • Birmingham, Alabama
    • +175 more
    2021-09-08
    Sep 8, 2021